TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post
press enter to search

LOG IN / REGISTER
The Jakarta Post - Logo Mobile

Popular Reads

No popular reads data found

Top Results

No results found. Please check your search term and try again

Can't find what you're looking for?

View all search results

Popular Reads

No popular reads data found

Top Results

No results found. Please check your search term and try again

Can't find what you're looking for?

View all search results

therapy

‘Didn’t understand my suffering’: When children get migraines
Health 3 years ago

PREMIUM
‘Didn’t understand my suffering’: When children get migraines

Studies have found that 5-15% of children suffer from chronic migraines, but the symptoms are often overlooked.
'Soul relief': Bees help mentally ill on Greek island
Health 3 years ago

'Soul relief': Bees help mentally ill on Greek island

But these are not ordinary beekeepers. Some of them are patients from the nearby psychiatric hospital, participating in a two-decade project combining therapy with professional fulfillment.
COVID-19 is not the only pandemic that needs to end
Academia 3 years ago

COVID-19 is not the only pandemic that needs to end

Harmful gender and social norms as well as legal barriers greatly hamper the HIV response, as highly affected communities fear accessing services. 
Does online therapy work for mental wellness?
Health 4 years ago

Does online therapy work for mental wellness?

Can a major problem like mental health be treated through a screen? 
Some antibody drugs for COVID-19 may not be effective on Omicron
Health 4 years ago

PREMIUM
Some antibody drugs for COVID-19 may not be effective on Omicron

The findings by Yoshihiro Kawaoka, a professor of virology at the University of Tokyo's Institute of Medical Science, and others were published in the New England Journal of Medicine on Wednesday.
GSK says tests show antibody drug works against Omicron
Health 4 years ago

GSK says tests show antibody drug works against Omicron

In a statement, the British drugmaker said that lab tests and a study on hamsters have demonstrated the sotrovimab antibody cocktail to work against viruses that were bio-engineered to carry a number of hallmark mutations of the Omicron variant.
Nowhere else to go: Safehouses for abused women
Lifestyle 4 years ago

Nowhere else to go: Safehouses for abused women

With domestic violence cases soaring during the pandemic, safehouses have become the last refuge for abused women. However, they struggle to carry on.
Merck COVID-19 pill seen as 'huge advance,' raises hope of preventing deaths
Health 4 years ago

PREMIUM
Merck COVID-19 pill seen as 'huge advance,' raises hope of preventing deaths

If it gets authorization, molnupiravir, which is designed to introduce errors into the genetic code of the virus, would be the first oral antiviral medication for COVID-19.
Mozart sonata can calm epiletic brain: Study
Science & Tech 4 years ago

PREMIUM
Mozart sonata can calm epiletic brain: Study

The research on 16 patients hospitalised with epilepsy that did not respond to medication has bolstered hopes that music could be used for new non-invasive treatments. 
AstraZeneca's antibody therapy prevents COVID-19, study shows
Health 4 years ago

AstraZeneca's antibody therapy prevents COVID-19, study shows

The company said on Friday that 75 percent of the participants in the trial for the therapy - two types of antibodies discovered by Vanderbilt University Medical Center - had chronic conditions including some with a lower immune response to vaccinations.
The Jakarta Post - Premium Subscription Banner
The Jakarta Post
The Jakarta Post - Apps Store Icon The Jakarta Post - Google Play Icon

© 2016 - 2026 PT. Bina Media Tenggara

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.